Cereblon (CRBN) inhibits prostate cancer metastasis by negatively regulating 6-phosphogluconate dehydrogenase (6PGD). - Guchhait K; Yoon HS; An HS; Shin S; Nam HS; Yanqui-Rivera FD; Oña SM; Mendez MÁ; Hwang JY; Park D; Park CS; Han JY; et al. (Oncogene, 2026)